Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Lucera Erick, Chief Financial Officer. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. Aggregated, 12 filings have been recorded. Split: 2 buys · 6 sells. Total volume traded: €305k. Activity tracked since 16 March 2023. The latest transaction was disclosed on 13 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lucera Erick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,000 shares@ US$6.81747.7% of flowCommon StockSEC:0001493152-23-008245:0
Canonical exit: 14 Jun 2023 (T+90)
12 of 12 declarations
About Lucera Erick
Lucera Erick is Chief Financial Officer and appears in 11 filings. Across the 11 sampled filings, from 2023-03-20 to 2026-06-26, purchases amount to EUR 27016 and sales to EUR 236962, with Cession as the modal transaction nature. The largest filings concern Editas Medicine, Inc., Dyne Therapeutics, Inc. and Beyond Air, Inc.